HomeCompareCFMS vs O

CFMS vs O: Dividend Comparison 2026

CFMS yields 88.11% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CFMS wins by $2.33M in total portfolio value
10 years
CFMS
CFMS
● Live price
88.11%
Share price
$2.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.37M
Annual income
$731,873.50
Full CFMS calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — CFMS vs O

📍 CFMS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFMSO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFMS + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CFMS pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFMS
Annual income on $10K today (after 15% tax)
$7,488.99/yr
After 10yr DRIP, annual income (after tax)
$622,092.48/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, CFMS beats the other by $617,755.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFMS + O for your $10,000?

CFMS: 50%O: 50%
100% O50/50100% CFMS
Portfolio after 10yr
$1.20M
Annual income
$368,488.12/yr
Blended yield
30.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CFMS
No analyst data
Altman Z
-12.5
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFMS buys
0
O buys
0
No recent congressional trades found for CFMS or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFMSO
Forward yield88.11%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$2.37M$34.2K
Annual income after 10y$731,873.50$5,102.74
Total dividends collected$2.08M$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CFMS vs O ($10,000, DRIP)

YearCFMS PortfolioCFMS Income/yrO PortfolioO Income/yrGap
1← crossover$19,511$8,810.57$10,818$608.16+$8.7KCFMS
2$36,942$16,065.36$11,787$741.68+$25.2KCFMS
3$67,956$28,428.44$12,946$911.00+$55.0KCFMS
4$121,587$48,874.33$14,345$1,127.94+$107.2KCFMS
5$211,824$81,725.42$16,056$1,409.05+$195.8KCFMS
6$359,715$133,063.84$18,171$1,777.83+$341.5KCFMS
7$596,079$211,183.71$20,820$2,268.21+$575.3KCFMS
8$964,860$327,055.60$24,188$2,929.90+$940.7KCFMS
9$1,527,165$494,764.27$28,533$3,837.11+$1.50MCFMS
10$2,365,940$731,873.50$34,235$5,102.74+$2.33MCFMS

CFMS vs O: Complete Analysis 2026

CFMSStock

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

Full CFMS Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this CFMS vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFMS vs SCHDCFMS vs JEPICFMS vs KOCFMS vs MAINCFMS vs STAGCFMS vs ADCCFMS vs NNNCFMS vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.